INSIGHTS ON CLINICAL TRIAL DESIGN
-
Evidence Of An Industry's Readiness To Collaborate
The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.
-
How Modern RTSM Platforms Are Eliminating Delays
Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.
-
How AI Is Reshaping Trial Design, Execution, And Disclosure
AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.
-
Digital Physical Activity Measures In Phase 3 Immunology Trials
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
-
Continuous Passive Monitoring's Effect On Sleep Disorder Research3/16/2026
Bridge the gap between clinical sleep studies and real-world behavior. Use continuous, wearable-enabled data to objectively measure daytime sleepiness and improve sleep disorder research.
-
Optimizing Movement Disorder Clinical Trials: A Focus On Parkinson's Disease8/25/2026
Join DVCR experts for a presentation on designing effective Parkinson's clinical trials. This webinar covers endpoint selection, patient-centered design, and real-world case studies.
-
Proving CNS Target Engagement With Neuroimaging In Early Clinical Drug Development8/27/2026
The key question is not whether a scan changes, but what link in the dose-to-effect chain it resolves. Combining PET, MRI, PK/PD, and functional measures reduces uncertainty.
-
Next-Generation ADC Trials – Turning Complexity Into Execution7/20/2026
As ADC science advances, operational strategy becomes critical. Learn how smarter protocol design, real-time monitoring and collaborative execution can accelerate next-generation ADC trials.
-
A High-Touch, Patient-Centered Approach For Advancing Rare Disease Trials4/15/2025
On your journey to developing and executing a successful rare disease trial, it is critical to focus on patient experience and accessibility from the earliest stages of trial design.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Automate protocol design, database builds, and validation to cut study setup from months to days — enabling faster analytics, earlier insights, and trial simulation.
-
Clinical trials often require travel coordination, reimbursements, and ongoing logistical support. Explore a service that centralizes those needs to help participants stay engaged.
-
Driven by AI and real-world data, Citeline PatientMatch helps sponsors identify highly qualified, protocol-matched patients earlier in their care journey — when enrollment decisions matter most.
-
Altasciences recruits from a large ethnic population in Southern California and have a dedicated Asian recruitment and outreach department to liaise with our participants.
-
Disconnected vendors mean disconnected data. Discover how a unified supply chain approach helps trial teams reduce risk, save time, and keep drug supply aligned with patient need.